COVID-19 vaccination in Senegal

Last updated

COVID-19 vaccination in Senegal
Date23 February 2021 - present
Location Senegal
Cause COVID-19 pandemic

On 23 February 2021, Senegal began its national vaccination program against the COVID-19. [1] As of 10 March, 68,205 people in Senegal have been able to be vaccinated. [2] [3]

Contents

History

Timeline

February 2021

On 23 February 2021, [4] Senegal began its national vaccination program against COVID-19 using the Sinopharm BIBP vaccine. [5]

March 2021

By the end of the month 309,128 vaccine doses had been administered, including 260,754 first doses.

April 2021

By the end of the month 470,009 vaccine doses had been administered, including 406,981 first doses.

May 2021

By the end of the month more than half a million vaccine doses had been administered, including 456,135 first doses.

June 2021

By the end of the month 0.7 million vaccine doses had been administered, including 0.5 million first doses.

July 2021

By the end of the month 1.1 million vaccine doses had been administered while 806,510 persons had been vaccinated. [6]

August 2021

By the end of the month 1.6 million vaccine doses had been administered while 1,167,364 persons had been vaccinated. [7]

September 2021

By the end of the month 1.8 million vaccine doses had been administered while 1,251,403 persons had been vaccinated. [8]

October 2021

By the end of the month 1.9 million vaccine doses had been administered, including 1.3 million first doses, and 13% of the targeted population had been fully vaccinated.

November 2021

By the end of the month 1.9 million vaccine doses had been administered, including 1.3 million first doses, and 13% of the targeted population had been fully vaccinated.

December 2021

By the end of the month two million vaccine doses had been administered, including 1.4 million first doses, and 14% of the targeted population had been fully vaccinated.

January 2022

By the end of the month two million vaccine doses had been administered, including 1.4 million first doses, and 14% of the targeted population had been fully vaccinated.

February 2022

By the end of the month 2.5 million vaccine doses had been administered, including 1.5 million first doses, while more than a million persons had been fully vaccinated.

March 2022

By the end of the month 2.5 million vaccine doses had been administered, including 1.5 million first doses, while more than a million persons had been fully vaccinated.

April 2022

By the end of the month 2.5 million vaccine doses had been administered, including 1.5 million first doses, while more than a million persons had been fully vaccinated.

Vaccine in order

VaccineApprovalDeployment
Sinopharm BIBP Green check.svg YesGreen check.svg 23 February 2021
Oxford–AstraZeneca Green check.svg YesGreen check.svg Yes

Progress

Cumulative vaccinations [3] The following figure presents the cumulative number of people in Senegal who have been vaccinated (vertical axis) since the starting date of vaccinations in Senegal (horizontal axis: date)

Related Research Articles

<span class="mw-page-title-main">COVID-19 pandemic in Senegal</span> Ongoing COVID-19 viral pandemic in Senegal

The COVID-19 pandemic in Senegal was a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Senegal on March 2, 2020.

<span class="mw-page-title-main">Sinopharm BIBP COVID-19 vaccine</span> Vaccine against COVID-19

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.

<span class="mw-page-title-main">COVID-19 vaccination in Zimbabwe</span> Plan to immunize against COVID-19

On 22 February 2021, Zimbabwe launched their national COVID-19 vaccination program using the Sinopharm BIBP vaccine. As of 17 June 2022, 6,260,228 people have received their first dose, 4,598,703 have received their second dose, and 851,874 have received a third dose.

On 29 January 2021, Algeria launched a COVID-19 vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines.822,109 people with the first dose and 492,266 people fully vaccinated. Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccination in Burkina Faso</span> Plan to immunize against COVID-19

Burkina Faso started vaccinating against COVID-19 on 2 June 2021.

Cape Verde has begun vaccinations against COVID-19.

<span class="mw-page-title-main">COVID-19 vaccination in Africa</span> Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs are ongoing in the majority countries and territories in Africa, with 51 of 54 African countries having launched vaccination programs by July 2021. As of October 2023, 51.8% of the continent's population is fully vaccinated with over 1084.5 million doses administered.

<span class="mw-page-title-main">COVID-19 vaccination in Ghana</span> Plan to immunize against COVID-19

COVID-19 vaccination in Ghana began on Monday 1 March 2021 after the country became the first recipient of the Oxford-AstraZeneca COVID-19 vaccine as part of the COVAX initiative. As of 6 June 2021, Ghana has administered 1,230,000 vaccine doses.

<span class="mw-page-title-main">COVID-19 vaccination in Nigeria</span> Plan to immunize against COVID-19

COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 28 February 2022, 17,914,944 people have received their first dose a COVID-19 vaccine, and 8,197,832 have received their second dose.

COVID-19 vaccination in Burundi is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Burundi was one of the last nation states in the world to commence vaccination against COVID-19. This was mostly due to the government's refusal to vaccinate the population throughout most of 2021. In February 2021, Thaddee Ndikumana, the health minister of Burundi, said his country was more concerned with prevention measures. "Since more than 95% of patients are recovering, we estimate that the vaccines are not yet necessary," local media reported.

COVID-19 vaccination in Cameroon is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Chad is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Djibouti is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Equatorial Guinea is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Eswatini is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in the Democratic Republic of the Congo is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

References

  1. AfricaNews (18 February 2021). "Senegal Kicks Off COVID-19 Vaccination Campaign with China's Sinopharm". Africanews. Archived from the original on 18 February 2021. Retrieved 12 March 2021.
  2. "One year after the start of the pandemic in Senegal, the country will receive a first batch of 324,000 doses of COVID-19 vaccine through the COVAX initiative - Senegal". ReliefWeb. 3 March 2021. Archived from the original on 3 March 2021. Retrieved 12 March 2021.
  3. 1 2 "owid/covid-19-data". GitHub. Archived from the original on 22 June 2021. Retrieved 12 March 2021.
  4. AfricaNews (23 February 2021). "Senegal begins covid-19 vaccination with doses from China's Sinopharm". Africanews. Archived from the original on 8 March 2021. Retrieved 12 March 2021.
  5. "Senegal: total COVID-19 vaccine doses 2021". Statista. Archived from the original on 11 August 2021. Retrieved 12 March 2021.
  6. "Sénégal : 1045 nouveaux cas testés positifs au coronavirus, 382 nouveaux guéris, 20 nouveaux décès et 76 cas graves en réanimation". Dakaractu (in French). 31 July 2021. Archived from the original on 2 August 2021. Retrieved 2 August 2021.
  7. Ndaw, Amadou (31 August 2021). "31 août au Sénégal: 52 nouveaux cas, 05 décès, 31 cas graves pour 72.805 cas au total". Dakar-Echo (in French). Archived from the original on 31 August 2021. Retrieved 1 September 2021.
  8. "Covid-19Sn: aucun cas de décès, 11 nouvelles contaminations et 6 cas graves en réanimation". PressAfrik (in French). 30 September 2021. Archived from the original on 10 October 2021. Retrieved 10 October 2021.